abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

文章

2021年7月22日

作者:
Evan Simko-Bednarski, CNN (USA)

USA: McKesson, Cardinal, & Amerisource Bergen settle New York state opioid lawsuit for $1.1 billion

"Three opioid distributors settle New York lawsuit for $1.1 billion", 20 Jul 2021

Three opioid distributors have settled a lawsuit with New York state to the tune of over $1 billion...

McKesson Corporation, Cardinal Health Inc. and Amerisource Bergen Drug Corporation have agreed to pay $1.1 billion towards opioid abatement efforts in the Empire State, according to the statement.

This effectively ends their participation in an ongoing civil suit in New York...

The money will be paid out over the course of the next 17 years, with the first payment coming in September.

The three distributors have also agreed to monitoring of their opioid shipments going forward, with a third-party, independent watchdog overseeing pharmacy-level distribution data pooled among the three companies.

McKesson, Cardinal, and Amerisource Bergen were sued by the State of New York in 2019, part of a sweeping lawsuit against a long slate of pharmaceutical manufacturers and distributors. At the time, James accused the companies of engaging in "years of deceptive marketing about the risks of opioids and (failure) to exercise their basic duty to report suspicious behavior."

Johnson & Johnson settled with the state last month, paying $230 million to resolve the suit. Several other defendants in the initial suit, including Purdue Pharma and distributor Rochester Drug Cooperative, have declared bankruptcy, and the cases against them are moving through the bankruptcy court system.

Three additional opioid manufacturers -- Endo Health Solutions, Teva Pharmaceuticals USA, Inc. and Allergan Finance, LLC -- continue to contest the state's claims at trial.

時間線

隱私資訊

本網站使用 cookie 和其他網絡存儲技術。您可以在下方設置您的隱私選項。您所作的更改將立即生效。

有關我們使用網絡儲存技術的更多資訊,請參閱我們的 數據使用和 Cookie 政策

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

分析cookie

ON
OFF

您瀏覽本網頁時我們將以Google Analytics收集信息。接受此cookie將有助我們理解您的瀏覽資訊,並協助我們改善呈現資訊的方法。所有分析資訊都以匿名方式收集,我們並不能用相關資訊得到您的個人信息。谷歌在所有主要瀏覽器中都提供退出Google Analytics的添加應用程式。

市場營銷cookies

ON
OFF

我們從第三方網站獲得企業責任資訊,當中包括社交媒體和搜尋引擎。這些cookie協助我們理解相關瀏覽數據。

您在此網站上的隱私選項

本網站使用 cookie 和其他網絡儲存技術來增強您在必要核心功能之外的體驗。